{
    "Case ID": "034093",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement Dispute"
    ],
    "Legal_Issue": [
        "Is Genpharm's allegation of noninfringement justified under the Patented Medicines (Notice of Compliance) Regulations?"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Procedural_Stage": [
        "Judicial review"
    ],
    "Evidence_Assessment": [
        "Genpharm's ticlopidine tablets do not contain any of the ten acids specified in the '170 patent; stearic acid used as a lubricant, not covered by patent claims"
    ],
    "Decision_Outcome": [
        "Application for prohibition dismissed"
    ],
    "Burden_of_Proof": [
        "On Hoffmann-La Roche to prove infringement"
    ],
    "Credibility_Factor": [
        "Genpharm's noninfringement allegation found justified"
    ],
    "Legal_Rule": [
        "Generic company must allege that no claim of the patent would be infringed by its product"
    ],
    "Standard_of_Review": [
        "Justified allegation under regulatory requirements"
    ],
    "Procedural_Issue": [
        "Compliance with regulatory requirements for noninfringement allegation"
    ],
    "Grounds_for_Claim": [
        "Hoffmann-La Roche challenged Genpharm's right to market ticlopidine without infringing their patent"
    ],
    "Outcome_on_Merits": [
        "Genpharm's allegation of noninfringement upheld"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Application dismissed"
    ],
    "Review_Standard": [
        "Whether noninfringement allegation met regulatory requirements"
    ],
    "Procedural_Fairness_Assessment": [
        "Regulatory process followed correctly by Genpharm"
    ],
    "Key_Evidence_Considered": [
        "Absence of specified acids in Genpharm's product; use of stearic acid as lubricant"
    ],
    "Legal_Framework": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Applicant_Challenge": [
        "Hoffmann-La Roche challenged Genpharm's NOC application"
    ],
    "Court_Result": [
        "Dismissed application for prohibition"
    ],
    "Legal_Rule_Source": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Genpharm alleged noninfringement based on formulation differences"
    ],
    "Evidence_Type": [
        "Product formulation data, patent claims analysis"
    ],
    "Remedy_Requested": [
        "Prohibition of Genpharm's market entry"
    ],
    "Outcome": [
        "Remedy denied; Genpharm allowed to proceed"
    ],
    "Decision_Authority": [
        "Federal Court or relevant judicial body"
    ],
    "Remedy_Sought": [
        "Prevent Genpharm from marketing ticlopidine"
    ],
    "Resolution_Mechanism": [
        "Judicial determination under regulatory framework"
    ],
    "Legal_Provision": [
        "Section(s) under the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Court"
    ],
    "Claimant_Status": [
        "Patent holder (Hoffmann-La Roche)"
    ],
    "Legal_Provision_Cited": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Noninfringement due to absence of patented components"
    ],
    "Applicable_Process": [
        "Notice of Compliance (NOC) proceedings"
    ],
    "Outcome_of_Review": [
        "Noninfringement allegation upheld"
    ],
    "Pending_Relief_or_Application": [
        "Application for prohibition of market entry"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ]
}